U.S. Interactive Media and Services Stock News

NYSE:ASIC
NYSE:ASICInsurance

A Look At Ategrity Specialty Insurance Company Holdings (ASIC) Valuation After Recent Share Price Surge

Ategrity Specialty Insurance Company Holdings (ASIC) has drawn fresh attention after a sharp recent move in its share price, with the stock up 6.1% over the past day and 32.7% in the past week. See our latest analysis for Ategrity Specialty Insurance Company Holdings. The recent surge in Ategrity Specialty Insurance Company Holdings’ share price, including a 32.7% 7 day share price return and a 23.97% 90 day share price return, suggests short term momentum is building while year to date...
NYSE:APAM
NYSE:APAMCapital Markets

Artisan Partners Expands Alternatives As Valuation Discount And Risks Persist

Artisan Partners Asset Management (NYSE:APAM) is expanding its alternatives platform and pursuing new partnerships to support growth. The company is pushing ahead with these initiatives while facing regulatory headwinds and changing client preferences. This shift in focus is intended to broaden its actively managed offering as more capital moves toward passive products. Artisan Partners has built its business around actively managed strategies, and the move into more alternative offerings...
NasdaqGS:LILA
NasdaqGS:LILATelecom

Liberty Latin America Rebuilds Jamaica Network And Seeks Value In 5G Shift

Liberty Latin America is rebuilding its network in Jamaica after Hurricane Melissa while keeping subscriber and B2B growth on track. The company is rolling out 5G standalone mobile services in partnership with Ericsson. Liberty Latin America is working with AWS on cloud and AI capabilities to support its telecom and enterprise offerings. Liberty Latin America, ticker NasdaqGS:LILA, is drawing attention as it works through major operational disruption while still adding postpaid mobile...
NasdaqGS:WING
NasdaqGS:WINGHospitality

Wingstop Tariffs And Labor Scrutiny Test Valuation And Growth Story

Wingstop (NasdaqGS:WING) is facing new global tariffs announced by the Trump administration, which affect international trade and input costs. The company is also under public scrutiny after a former employee publicly alleged issues with labor and management practices. Social media conversations have amplified these accusations, raising questions for customers, employees, and investors. Wingstop, known for its chicken wing restaurants and franchise model, relies on international supply...
NasdaqGS:WGS
NasdaqGS:WGSHealthcare

GeneDx Holdings (WGS) Q4 Loss Of US$17.7 Million Tests Bullish Profitability Narrative

GeneDx Holdings (WGS) closed out FY 2025 with Q4 revenue of US$121.0 million and a basic EPS loss of US$0.61, alongside net income excluding extraordinary items of a US$17.7 million loss. Over recent quarters the company has seen revenue move from US$95.6 million in Q4 2024 to US$121.0 million in Q4 2025, while quarterly basic EPS has ranged from a loss of US$0.31 in Q3 2024 to a gain of US$0.38 in Q2 2025 and back to a loss of US$0.61 in the latest period. This sets up a story in which...
NasdaqGS:BEAM
NasdaqGS:BEAMBiotechs

Beam Therapeutics Taps US$500m Non Dilutive Debt To Back Risto Cel

Beam Therapeutics entered a long term, non dilutive financing agreement with Sixth Street to support the potential launch of its sickle cell gene therapy. The deal provides access to up to $500 million in capital tied to Beam’s commercial plans for this program. The agreement focuses on funding potential product launch and commercialization activities rather than issuing new equity. For investors watching NasdaqGS:BEAM, this financing move comes with the stock trading around $28.33 and a...
NYSE:ELS
NYSE:ELSResidential REITs

Is Equity LifeStyle Properties (ELS) Price Still Reasonable After Recent DCF Upside Signal

Wondering if Equity LifeStyle Properties at around US$67.96 is offering fair value right now, or if the price is running ahead of reality? The stock has returned 0.2% over the past week, 6.2% over the last month, 13.7% year to date, 4.8% over 1 year, 8.0% over 3 years and 26.3% over 5 years. This provides a mix of short and longer term outcomes to weigh up. Recent news coverage has focused on Equity LifeStyle Properties as a large US listed real estate owner and operator, with investors...
NasdaqGM:AXSM
NasdaqGM:AXSMPharmaceuticals

Axsome Therapeutics Q4 Revenue Surge Tests Bulls’ Profitability Narrative

Axsome Therapeutics (AXSM) closed FY 2025 with Q4 revenue of US$196.0 million and a basic EPS loss of US$0.56, alongside a net income loss of US$28.6 million, keeping profitability firmly in focus for investors. The company has seen quarterly revenue move from US$118.8 million in Q4 2024 to US$196.0 million in Q4 2025, while basic EPS has shifted from a loss of US$1.54 to a loss of US$0.56 over the same period. This frames a story where top line scale is running ahead of bottom line progress...
NYSE:NPO
NYSE:NPOMachinery

How Investors Are Reacting To Enpro (NPO) 2026 Growth Targets, Dividend Bump, And M&A Capacity

Enpro Inc. reported past fourth-quarter 2025 sales of US$295.4 million and a net loss of US$32 million, issued 2026 revenue growth guidance of 8% to 12%, and signaled ongoing capacity for acquisitions under its Enpro 3.0 framework. The company is pairing a small quarterly dividend increase to US$0.32 per share with plans to pursue acquisitions that add technology, talent, and process expertise in its key growth areas. We’ll now examine how Enpro’s 2026 revenue guidance and acquisition...
NYSE:PFGC
NYSE:PFGCConsumer Retailing

Is Performance Food Group (PFGC) Still Attractive After Its Recent Share Price Gains

If you are wondering whether Performance Food Group's share price still offers value at around US$95.79, you are not alone. Many investors are asking the same question before making their next move. The stock has seen a 2.3% decline over the last 7 days, a 2.0% gain over 30 days, and is up 8.8% year to date, with a 15.6% return over 1 year, 65.2% over 3 years and 70.9% over 5 years. These figures may influence how you think about its risk and reward trade off. Recent company updates and...
NYSE:KEX
NYSE:KEXShipping

Is Kirby (KEX) Fairly Priced After Doubling Over Five Years?

If you are wondering whether Kirby's current share price truly reflects its underlying value, you are not alone. That is exactly what this article will unpack. With the stock at US$128.46 after a 2.8% gain over the last 7 days, a flat 0.2% move over 30 days, and returns of 14.8% year to date, 27.3% over 1 year, 76.4% over 3 years and 100.0% over 5 years, many investors are asking what is already priced in. Recent attention on Kirby has largely centered on its role in the U.S. marine...
NasdaqGS:LAMR
NasdaqGS:LAMRSpecialized REITs

Assessing Lamar Advertising (LAMR) Valuation After Recent Share Price Moves And Long Term Returns

Lamar Advertising (LAMR) is back on investor radars after recent share price moves, with the stock closing at US$132.03. That puts fresh attention on how its billboard focused business is currently valued. See our latest analysis for Lamar Advertising. While the latest move leaves Lamar Advertising at US$132.03 after a 1 day share price return of a 1.46% decline, the year to date share price return of 6.37% and 1 year total shareholder return of 12.69% sit within a much stronger 5 year total...
NYSE:CMRE
NYSE:CMREShipping

Costamare (CMRE) Valuation Check After Earnings Show Higher Profitability On Slightly Lower Revenue

Why Costamare’s latest earnings matter for shareholders Costamare (CMRE) recently reported fourth quarter and full year 2025 results, with net income and earnings per share rising while revenue edged lower. This puts the focus squarely on profitability and the durability of its charter driven cash flows. See our latest analysis for Costamare. At a share price of US$16.77, Costamare has had a 30 day share price return of 5.34% and a 90 day gain of 9.90%. Its 1 year total shareholder return of...
NYSE:HIW
NYSE:HIWOffice REITs

Is Highwoods Properties (HIW) An Opportunity After Prolonged Share Price Weakness?

Wondering whether Highwoods Properties is priced attractively at its current level, or if the value story is not as clear as it looks at first glance? The stock last closed at US$22.91, with returns of 0.9% decline over 7 days, 13.1% decline over 30 days, 11.5% decline year to date, 14.9% decline over 1 year, 8.6% over 3 years and 22.0% decline over 5 years. This performance may have some investors reassessing both risk and opportunity. Recent coverage around Highwoods Properties has focused...
NasdaqGS:TCBI
NasdaqGS:TCBIBanks

Texas Capital Bancshares Insider Buying Aligns With Cleaner Capital Structure

Texas Capital Bancshares (NasdaqGS:TCBI) has simplified its capital structure by eliminating unused classes of preferred and nonvoting stock. A board director recently made a significant insider purchase of TCBI shares, signaling personal commitment to the company. Both actions highlight changes in capital structure and insider alignment that had not been covered previously. Texas Capital Bancshares, the parent of Texas Capital Bank, focuses on commercial and consumer banking services in...
NasdaqGS:KDP
NasdaqGS:KDPBeverage

Does KDP’s Coffee Spinoff and New Drink Pipeline Change The Bull Case For Keurig Dr Pepper (KDP)?

Keurig Dr Pepper recently expanded its 2026 innovation slate with more than 35 new beverage varieties across carbonated soft drinks, teas, waters, energy and juice drinks, while also refreshing legacy brands like Snapple and Canada Dry Fruit Splash Strawberry. At the same time, the company is reshaping its governance and business mix ahead of earnings by adding two experienced independent directors, progressing toward the JDE Peet’s acquisition and planning a separation into Beverage Co. and...
NYSE:D
NYSE:DIntegrated Utilities

Dominion Energy (D) Earnings Surge Of 60.5% Tests Dividend And Interest Coverage Concerns

Dominion Energy (D) has laid out its FY 2025 scorecard with third quarter revenue of US$4.5b and basic EPS of US$1.17, capped by trailing twelve month revenue of US$16.5b and EPS of US$3.47 that sit against a 60.5% year over year earnings jump and a 5.7% five year average earnings growth rate. The company has seen quarterly revenue move from US$3.4b in Q4 2024 to US$4.1b in Q1 2025, US$3.8b in Q2 2025 and US$4.5b in Q3 2025. Basic EPS shifted from a Q4 2024 loss of US$0.13 per share to...
NYSE:KNTK
NYSE:KNTKOil and Gas

Kinetik Holdings Weighs Sale As Western Midstream Interest Meets Rich Valuation

Kinetik Holdings (NYSE:KNTK) is reported to be exploring a potential sale process. Western Midstream Partners has shown interest in a possible acquisition of Kinetik Holdings. The situation points to possible changes in ownership structure and future direction for the company. Kinetik Holdings, listed on the NYSE under ticker KNTK, operates in the midstream energy space, connecting upstream production with downstream demand through gathering, processing, and related services. Attention on...
NYSE:WSO
NYSE:WSOTrade Distributors

Watsco Dividend Raised 10% As Valuation And Cash Coverage Weighed

Watsco (NYSE:WSO) announced that its Board of Directors approved a 10% increase in its annual dividend. The decision represents a material change in the company’s capital return to shareholders. Watsco, a large distributor of air conditioning, heating and refrigeration equipment, sits at the crossroads of residential and commercial demand for climate systems. For income focused investors, a 10% increase in the annual dividend is a meaningful signal about how the Board views the company’s...
NasdaqGS:CRNX
NasdaqGS:CRNXPharmaceuticals

Crinetics Progresses Rare Endocrine Pipeline With New Data And Early Sales

Crinetics Pharmaceuticals (NasdaqGS:CRNX) reported positive clinical trial results for its congenital adrenal hyperplasia treatment. The company also announced positive initial sales for its oral therapy for acromegaly, alongside progress on related regulatory milestones. These updates highlight recent clinical and commercial developments in Crinetics' rare endocrine disease portfolio. Crinetics Pharmaceuticals focuses on therapies for rare endocrine conditions, an area where treatment...
NYSE:ARI
NYSE:ARIMortgage REITs

A Look At Apollo Commercial Real Estate Finance (ARI) Valuation After Full Year Return To Profitability

What the latest earnings and buyback update means for Apollo Commercial Real Estate Finance (ARI) Apollo Commercial Real Estate Finance (ARI) just released fourth quarter and full year 2025 results, reporting quarterly income of US$29.2 million and a full year return to profitability, alongside the completion of a multi year share repurchase program. See our latest analysis for Apollo Commercial Real Estate Finance. The latest earnings rebound and completion of a multi year buyback sit...
NYSE:TX
NYSE:TXMetals and Mining

Is It Time To Reassess Ternium (NYSE:TX) After A 59% One Year Share Price Gain

If you are wondering whether Ternium's current share price gives you good value, this article walks through what the numbers actually say and how that lines up with different valuation methods. Ternium's stock closed at US$43.33, with a 1 year return of 59.4% and a 5 year return of 96.2%. This comes even though the shares show a 0.7% decline over 7 days, a 1.1% decline over 30 days, and a 10.7% gain year to date. Recent coverage has put a spotlight on how investors are weighing steel demand,...
NYSE:MANU
NYSE:MANUEntertainment

Is Manchester United (MANU) Pricing Reflect Future Ownership Shifts Or Recent Steady Share Performance

With Manchester United stock trading at around US$17.40, this article considers whether that price represents a bargain or reflects the club's famous name, and explores what the current market valuation might be implying about the club's overall worth. The share price has been relatively steady in the very short term, with a 0.2% decline over the last 7 days, a 1.3% gain over 30 days, and returns of 10.3% year to date and 18.0% over the past year, compared with weaker figures over 3 and 5...
NYSE:TEVA
NYSE:TEVAPharmaceuticals

Has Teva (TEVA) Run Too Far After Its 102% One-Year Share Price Surge?

If you are wondering whether Teva Pharmaceutical Industries is still good value after its recent run, this article walks through what the current share price might be implying about the company. Teva's share price last closed at US$33.91, with returns of 6.6% over the past 30 days, 9.6% year to date and 102.1% over the last year. The 3 year and 5 year returns sit at 242.5% and 210.5% respectively, which raises the question of how much optimism is already reflected in the price. Recent...